These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23369548)

  • 1. Analysis of vesicular monoamine transporter 2 polymorphisms in Parkinson's disease.
    Brighina L; Riva C; Bertola F; Saracchi E; Fermi S; Goldwurm S; Ferrarese C
    Neurobiol Aging; 2013 Jun; 34(6):1712.e9-13. PubMed ID: 23369548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association analysis of polymorphisms in VMAT2 and TMEM106B genes for Parkinson's disease, amyotrophic lateral sclerosis and multiple system atrophy.
    Hu T; Chen Y; Ou R; Wei Q; Cao B; Zhao B; Wu Y; Song W; Chen X; Shang HF
    J Neurol Sci; 2017 Jun; 377():65-71. PubMed ID: 28477711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association between polymorphic microsatellites of the VMAT2 gene and Parkinson's disease in Japan.
    Kariya S; Hirano M; Takahashi N; Furiya Y; Ueno S
    J Neurol Sci; 2005 May; 232(1-2):91-4. PubMed ID: 15850588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hVMAT2: A Target of Individualized Medication for Parkinson's Disease.
    Xiong N; Li N; Martin E; Yu J; Li J; Liu J; Lee DY; Isacson O; Vance J; Qing H; Wang T; Lin Z
    Neurotherapeutics; 2016 Jul; 13(3):623-34. PubMed ID: 27137201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism in the Vesicular Monoamine Transporter 2 Gene Decreases the Risk of Parkinson's Disease in Han Chinese Men.
    Yang X; Xu P; Zhao Q; An R; Jia H; Liu Z; Xu Y
    Parkinsons Dis; 2015; 2015():903164. PubMed ID: 26246935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vesicular monoamine transporter 2 mRNA levels are reduced in platelets from patients with Parkinson's disease.
    Sala G; Brighina L; Saracchi E; Fermi S; Riva C; Carrozza V; Pirovano M; Ferrarese C
    J Neural Transm (Vienna); 2010 Sep; 117(9):1093-8. PubMed ID: 20665056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gain-of-function haplotypes in the vesicular monoamine transporter promoter are protective for Parkinson disease in women.
    Glatt CE; Wahner AD; White DJ; Ruiz-Linares A; Ritz B
    Hum Mol Genet; 2006 Jan; 15(2):299-305. PubMed ID: 16339215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased vulnerability to L-DOPA toxicity in dopaminergic neurons From VMAT2 heterozygote knockout mice.
    Kariya S; Takahashi N; Hirano M; Ueno S
    J Mol Neurosci; 2005; 27(3):277-79. PubMed ID: 16280597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease.
    Miller GW; Erickson JD; Perez JT; Penland SN; Mash DC; Rye DB; Levey AI
    Exp Neurol; 1999 Mar; 156(1):138-48. PubMed ID: 10192785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VMAT2 and Parkinson's disease: harnessing the dopamine vesicle.
    Lohr KM; Miller GW
    Expert Rev Neurother; 2014 Oct; 14(10):1115-7. PubMed ID: 25220836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity.
    Taylor TN; Caudle WM; Shepherd KR; Noorian A; Jackson CR; Iuvone PM; Weinshenker D; Greene JG; Miller GW
    J Neurosci; 2009 Jun; 29(25):8103-13. PubMed ID: 19553450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic elimination of dopamine vesicular stocks in the nigrostriatal pathway replicates Parkinson's disease motor symptoms without neuronal degeneration in adult mice.
    Isingrini E; Guinaudie C; C Perret L; Rainer Q; Moquin L; Gratton A; Giros B
    Sci Rep; 2017 Sep; 7(1):12432. PubMed ID: 28963508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Gene Polymorphism of VMAT2 Is Associated with Risk of Schizophrenia in Male Han Chinese.
    Han H; Xia X; Zheng H; Zhao C; Xu Y; Tao J; Wang X
    Psychiatry Investig; 2020 Nov; 17(11):1073-1078. PubMed ID: 33099987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MPTP Mouse Model of Preclinical and Clinical Parkinson's Disease as an Instrument for Translational Medicine.
    Mingazov ER; Khakimova GR; Kozina EA; Medvedev AE; Buneeva OA; Bazyan AS; Ugrumov MV
    Mol Neurobiol; 2018 Apr; 55(4):2991-3006. PubMed ID: 28456940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of VEGF gene polymorphisms with sporadic Parkinson's disease in Chinese Han population.
    Wu Y; Zhang Y; Han X; Li X; Xue L; Xie A
    Neurol Sci; 2016 Dec; 37(12):1923-1929. PubMed ID: 27481110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association study of the vesicular monoamine transporter gene SLC18A2 with tardive dyskinesia.
    Zai CC; Tiwari AK; Mazzoco M; de Luca V; Müller DJ; Shaikh SA; Lohoff FW; Freeman N; Voineskos AN; Potkin SG; Lieberman JA; Meltzer HY; Remington G; Kennedy JL
    J Psychiatr Res; 2013 Nov; 47(11):1760-5. PubMed ID: 24018103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of VMAT2 gene polymorphisms with alcohol dependence.
    Fehr C; Sommerlad D; Sander T; Anghelescu I; Dahmen N; Szegedi A; Mueller C; Zill P; Soyka M; Preuss UW
    J Neural Transm (Vienna); 2013 Aug; 120(8):1161-9. PubMed ID: 23504072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vesicular integrity in Parkinson's disease.
    Alter SP; Lenzi GM; Bernstein AI; Miller GW
    Curr Neurol Neurosci Rep; 2013 Jul; 13(7):362. PubMed ID: 23690026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.
    Wile DJ; Agarwal PA; Schulzer M; Mak E; Dinelle K; Shahinfard E; Vafai N; Hasegawa K; Zhang J; McKenzie J; Neilson N; Strongosky A; Uitti RJ; Guttman M; Zabetian CP; Ding YS; Adam M; Aasly J; Wszolek ZK; Farrer M; Sossi V; Stoessl AJ
    Lancet Neurol; 2017 May; 16(5):351-359. PubMed ID: 28336296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons.
    Liang CL; Nelson O; Yazdani U; Pasbakhsh P; German DC
    J Comp Neurol; 2004 May; 473(1):97-106. PubMed ID: 15067721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.